CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR

Launched by WAIKATO HOSPITAL · May 24, 2022

Keywords

ClinConnect Summary

This clinical trial is investigating the use of a device called continuous positive airway pressure (CPAP) during radiotherapy for patients with breast cancer, as well as those receiving treatment for lung and liver cancers. The goal is to see if using CPAP can help create a better radiation treatment plan by improving the way patients breathe during therapy. CPAP may help move the heart away from the area being treated, reduce the amount of healthy lung tissue exposed to radiation, and minimize movement of the treatment area, which can lead to more effective radiation therapy.

To participate in this trial, patients must have a confirmed diagnosis of invasive breast cancer and be scheduled for radiation treatment, or they must be eligible for specialized radiation therapy for lung or liver cancers. Participants should be able to tolerate the CPAP device, so those with severe claustrophobia or who are undergoing re-irradiation may not be eligible. If enrolled, patients will have the chance to contribute to important research that may improve radiation treatments for cancer. The trial is not yet recruiting participants, but it's an exciting opportunity for those who meet the criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any patient with pathologically-confirmed invasive breast cancer and planned for adjuvant radiotherapy to the breast or chest-wall with regional lymph node coverage
• • Any patient deemed suitable for lung or liver SABR as per departmental guidelines
• • Must have signed written informed consent
• Exclusion Criteria:
• • Cannot tolerate CPAP e.g due to severe claustrophobia
• • Re-irradiation